Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.857
-0.003 (-0.36%)
At close: Mar 9, 2026, 4:00 PM EDT
0.857
+0.000 (0.05%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $20.08 million as of March 9, 2026. Its market cap has decreased by -74.87% in one year.
Market Cap
20.08M
Enterprise Value
8.28M
1-Year Change
-74.87%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $20.08M, a decrease of -90.38%. That is a compound annual growth rate of -42.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.15M | -42.28% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IO Biotech | 21.62M |
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |